|
|
espa�ol - fran�ais - portugu�s |
Search
|
India - Patent Protection for Pharmaceutical and Agricultural Chemical ProductsComplaint by the European Communities and their member States Report of the Panel 4.24 According to India, the Panel faced conflicting signals from the Appellate Body. The Panel could not follow in the present dispute the reasoning in the previous dispute and base its interpretation of Article 70.9 on the notion of predictability of conditions of competition without risking that it would be castigated for misapplying Article 31 of the Vienna Convention and failing to examine the words of the treaty to determine the intention of the parties. However, if the Panel based its interpretation exclusively on the language of Article 70.9 itself, it was bound to arrive at a conclusion that was different from the one reached by the Appellate Body in the previous case. India requested the Panel to resolve this dilemma in the light of the following two rulings of the Appellate Body. The first was: "Both panels and the Appellate Body must be guided by the rules of treaty interpretation set out in the Vienna Convention, and must not add to or diminish rights and obligations provided in the WTO Agreement. "This conclusion is dictated by two separate and very specific provisions of the DSU. Article 3.2 of the DSU provides that the dispute settlement system of the WTO: ""... serves to preserve the rights and obligations of the Members under the covered agreements, and to clarify the existing provisions of those agreements in accordance with customary rules of interpretation of public international law. Recommendations and rulings of the DSB cannot add to or diminish the rights and obligations provided in the covered agreements." "Furthermore, Article 19.2 of the DSU provides: ""In accordance with paragraph 2 of Article 3, in their findings and recommendations, the panel and Appellate Body cannot add to or diminish the rights and obligations provided in the covered agreements." "These provisions speak for themselves. Unquestionably, both panels and the Appellate Body are bound by them."74 The second ruling of the Appellate Body that the Panel should take into account was the following: "We do not believe that the CONTRACTING PARTIES, in deciding to adopt a panel report, intended that their decision would constitute a definitive interpretation of the relevant provisions of the GATT 1947. Nor do we believe that this is contemplated under GATT 1994. There is a specific cause for this conclusion in the WTO Agreement. Article IX:2 of the WTO Agreement provides: "The Ministerial Conference and the General Council shall have the exclusive authority to adopt interpretations of this Agreement and of the Multilateral Trade Agreements"... . The fact that such an "exclusive" authority in interpreting the treaty has been established so specifically in the WTO Agreement is reason enough to conclude that such authority does not exist by implication or by inadvertence elsewhere."75 It followed from the above that the Panel was strictly bound by the principles of interpretation referred to in Article 3.2 of the DSU, but not by the rulings of panels and the Appellate Body in a single instance and therefore had no option but to base its interpretation of Article 70.9 of the TRIPS Agreement exclusively on Article 31 of the Vienna Convention. 4.25 The European Communities and their member States were of the view that India had not advanced any new elements that had not yet been considered in the earlier dispute or that were otherwise relevant for the resolution of the present dispute.
4.26 Commenting on the views expressed by the European Communities and their member States, India noted that the EC had not claimed that India had denied any exclusive marketing rights to European companies and had not refuted India's argument that the terms of Artice 70.9 did not require the establishment of a system for the grant of exclusive marketing rights, but merely required the grant of such rights to particular products meeting specified conditions. India further noted that the EC refused to address the arguments presented by India. V. Arguments Presented By Third Party United States Procedural history of the related dispute 5.1 The United States argued in its third party submission that the precise measures and provisions of the WTO Agreement at issue in this dispute had been the subject of a previous WTO dispute settlement proceeding that had concluded very recently. This did not mean that the European Communities and their member States did not have the right to bring this complaint; the DSU did not deny the EC the right to do so. However, the Appellate Body had thoroughly analyzed the legal issues in the case and it was neither necessary nor appropriate for the Panel to repeat that work. The Panel should consider the arguments of the parties, but be guided by the Appellate Body�s recent interpretation of the obligations at issue. In accordance with this approach, the Panel should find that India had failed to comply with Article 70.8 and 70.9 of the TRIPS Agreement and recommend that India amend its law to comply with these obligations. 5.2 The United States, describing the procedural history of the earlier dispute (WT/DS50 - United States' complaint against India regarding patent protection for pharmaceuticals and agricultural chemicals), said that the Panel in that dispute had been established by the DSB on 20 November 1996 and had issued its report on 5 September 1997.77 In its report, the Panel had found that India had failed to comply with Articles 70.8, 70.9 and 63 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). India had appealed these findings to the Appellate Body, which had upheld the Panel�s conclusions with respect to Article 70.8 and 70.9.78 The Panel and the Appellate Body had considered India's arguments with respect to the obligations in Article 70.8 and 70.9 of the TRIPS Agreement and, after analysing the text, context, object and purpose of Article 70.8, concluded that the provision required the establishment of a mailbox system that provided a "sound legal basis" for filing product patent applications for pharmaceuticals and agricultural chemicals.79 Both the Panel and the Appellate Body had examined the evidence presented regarding India's Patents Act (1970)80 and then concluded that India had failed to comply with Article 70.8 of the TRIPS Agreement.81 With respect to Article 70.9, the Panel and the Appellate Body had determined that this provision required the establishment of a system for granting exclusive marketing rights as of 1 January 1995. By India's own admission, it had not established such a system. Consequently, the Panel and the Appellate Body had found that India had failed to comply with Article 70.9 of the TRIPS Agreement.82 The DSB had adopted the Panel and Appellate Body reports on 16 January 1998. On 13 February 1998, India had indicated its intention to implement the DSB's recommendations and rulings. India and the United States had not reached an agreement regarding the time in which India would implement these recommendations and rulings; that issue might have to be decided by arbitration in accordance with Article 21.3 of the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU). India thus had not yet amended its law to comply with its obligations under Article 70.8 and 70.9 of the TRIPS Agreement and had not argued in this proceeding that the situation was otherwise. Under Article 10.4 of the DSU, WTO Members were entitled to bring complaints regarding matters that had been the subject of a previous panel proceeding 5.3 Commenting on India's argument that the Panel should dismiss the EC's complaint on the basis of Articles 9.1 and 10.4 of the DSU, the United States said that these provisions did not support dismissal of the EC's complaint, but rather indicated a pronounced concern for safeguarding the rights of multiple complainants and third parties.
In examining the complaint brought by the EC, the Panel should apply the interpretation of Article 70.8 and 70.9 of the TRIPS Agreement of the Panel and the Appellate Body in the earlier case 5.4 The United States supported the view of the EC that it was not necessary or appropriate to repeat all of the legal arguments made in the earlier dispute (WT/DS50) in the context of the present proceedings. India had failed to comply with Article 70.8 and 70.9 of the TRIPS Agreement. The Appellate Body had already analysed the obligations in Article 70.8 and 70.9 and determined that India had failed to comply with those obligations. It was undisputed that India had not amended its Patents Act since the Appellate Body had issued its ruling three months ago.
Article 3.8 of the DSU 5.5 Commenting on the approach that the Panel should take in the present dispute, the United States expressed the view that the Panel should presume that India's non-compliance with Article 70.8 and 70.9 had had an adverse impact on right holders in the European Communities, but that India was entitled to present evidence to rebut that presumption. Article 3.8 of the DSU provided that "In cases where there is an infringement of the obligations assumed under a covered agreement, the action is considered prima facie to constitute a case of nullification or impairment. This means that there is normally a presumption that a breach of the rules has an adverse impact on other Members parties to that covered agreement, and in such cases, it shall be up to the Member against whom the complaint has been brought to rebut the charge". According to the analysis of the Appellate Body, India's legal regime did not comply with Article 70.8 and 70.9 of the TRIPS Agreement. This Panel should therefore follow the Appellate Body's analysis and reach the same conclusion. If the Panel reached this conclusion, under Article 3.8 of the DSU, the EC was entitled to a presumption that India's breach of the TRIPS Agreement had had an adverse impact on the nationals of its member States.85 5.6 Of course, this presumption was a rebuttable one and the Panel should consider any evidence presented by India that its failure to comply with Article 70.8 and 70.9 had not nullified or impaired benefits to the European Communities and their member States. Continuation: Interim Review
74 Document WT/DS50/AB/R, paragraph 47 75 Appellate Body Report on Japan - Taxes on Alcoholic Beverages, Section E (WT/DS8/AB/R, WT/DS10/AB/R, WT/DS11/AB/R) 76 See Annex 4 below. 77 Document WT/DS50/R 78 Document WT/DS50/AB/R 79 Document WT/DS50/AB/R, paragraph 58; document WT/DS50/R, paragraph 7.28 80 Document WT/DS50/AB/R, paragraph 69; document WT/DS50/R, paragraph 7.35 81 Document WT/DS50/AB/R, paragraph 97; document WT/DS50/R, paragraph 8.1 82 Document WT/DS50/AB/R, paragraph 97; document WT/DS50/R, paragraph 8.1 83 DSU, Article 3.2 84 DSU, Article 3.2 (emphasis added) 85 In a scenario involving two successive disputes concerning the same matter and legal claims, such a presumption would not necessarily exist in the later case if the earlier case concerned solely "non-violation" nullification or impairment. |
|